Global deletion of Gprc6a in mice induces metabolic disorders, such as hyperglycemia, glucose intolerance, insulin resistance, hepatic steatosis, osteopenia, and feminization of males (9). This evidence concerns the gene GPRC6A and Other metabolic disease.